Plant-derived Lignans Synthesis and Bioactivity
Plant-derived Lignans Synthesis and Bioactivity is a research topic within Molecular Biology. Science Explorer counts 5.8k research works in it since 1951. 10.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the biosynthesis, pharmacological activities, and medicinal applications of lignans, including compounds such as podophyllotoxin, schisandrin, arctigenin, and related derivatives. It covers research on various plant sources, enzymatic pathways, cytotoxicity, anti-inflammatory effects, and potential therapeutic uses of lignans in cancer treatment, neuroprotection, hepatoprotection, and antimicrobial activities.
- Lignans
- Biosynthesis
- Pharmacological Activities
- Anticancer Agents
- Antioxidant
- Medicinal Plants
- Podophyllotoxin
- Schisandra chinensis
- Arctium lappa
- Dirigent Proteins
- Research works
- 5.8k fractional, since 1951
- In the world top 10%
- 607 per year above
- Top-10% rate
- 10.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +1% the tick is no change
Which countries lead Plant-derived Lignans Synthesis and Bioactivity research?
By volume, China and India publish the most (407 and 66 works in 2022–2025).
By volume, 2022–2025
- 1 China 407 works
- 2 India 66 works
- 3 South Korea 42 works
- 4 Indonesia 38 works
- 5 Japan 33 works
- 6 United States 32 works
- 7 Vietnam 20 works
- 8 Brazil 19 works
- 9 Iran 17 works
- 10 Taiwan 16 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Plant-derived Lignans Synthesis and Bioactivity research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Plant-derived Lignans Synthesis and Bioactivity research, followed by Shenyang Pharmaceutical University and Heilongjiang University of Chinese Medicine.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
- 2 Shenyang Pharmaceutical UniversityChina 8 works
- 3 Heilongjiang University of Chinese MedicineChina 8 works
- 4 Vietnam Academy of Science and TechnologyVietnam 7 works
- 5 Chengdu University of Traditional Chinese MedicineChina 6 works
- 6 Hunan University of Traditional Chinese MedicineChina 5 works
- 7 First Affiliated Hospital of Henan UniversityChina 5 works
- 8 Shaanxi University of Chinese MedicineChina 5 works
- 9 Guizhou UniversityChina 5 works
- 10 Chinese Academy of SciencesChina 5 works
Where is Plant-derived Lignans Synthesis and Bioactivity research done?
The largest centres of Plant-derived Lignans Synthesis and Bioactivity research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Guangzhou.
Largest cities, 2022–2025
Where it is the local speciality
- GuangzhouCN · 20.4 works2.7×
Location quotient: how much more of its research is in Plant-derived Lignans Synthesis and Bioactivity than the world average.
Where is the best place to study Plant-derived Lignans Synthesis and Bioactivity?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 0.0 | 11.0% | 19.2× | 16 | -25.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Plant-derived Lignans Synthesis and Bioactivity research growing?
Output in 2018–2022 was 1% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Plant-derived Lignans Synthesis and Bioactivity.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.